Table 2.
Expression levels of BALF GM and serum biomarkers in the different groups.
| No IPA | Possible IPA | Probable/proven IPA | |
| BALF GM (ODI) | 0.25[0.178 0.368] | 0.733[0.426 1.77] | 2.66[0.548 4.104] |
| ≥0.5 ODI | 26 (12.56%) | 64 (69.57%) | 26 (75.47%) |
| ≥1.0ODI | 6 (2.9%) | 37 (40.22%) | 21 (61.76%) |
| Serum GM (ODI) | 0.163[0.113 0.227] | 0.2[0.119 0.34] | 0.31[0.185 0.975] |
| ≥0.5 ODI | 10 (4.83%) | 11 (11.96%) | 15 (44%) |
| ≥1.0 ODI | 2 (0.96%) | 6 (6.52%) | 8 (2.35%) |
| Serum BDG∗ | |||
| >10 pg/ml | 8 (3.86%) | 4 (4.34%) | 6 (17.64%) |
| >20 pg/ml | 5 (2.41%) | 1 (1.08%) | 6 (17.64%) |
| PCT (μg/L) | 0.06[0.03 0.12] | 0.10[0.04 0.56] | 0.12[0.04 1.69] |
| CRP (mg/L) | 20.17[4.63 63.36] | 54.45[11.97 144.55] | 73.92[40.03,169.72] |
BALF = bronchoalveolar lavage fluid, BDG = 1,3-β-d-glucan, CRP = C-reactive protein, GM = galactomannan, IPA = invasive pulmonary aspergillosis, ODI = optical density index, PCT = procalcitonin.
The data of ODI, PCT, and CRP in different groups were not in accordance with normal distribution and were expressed by median and interquartile range.
∗
The methodology of serum BDG used 10 pg/ml as the detection limit of a positive result, so serum BDG was not analyzed as a digital variable.